Advertisement

Pneumo News

, Volume 11, Issue 3, pp 24–32 | Cite as

Differenzialdiagnose und Therapie

Entscheidend bei Lungenembolie ist die hämodynamische Stabilität

  • Henning LemmEmail author
  • Michael Buerke
cme fortbildung
  • 355 Downloads

Zusammenfassung

Die Lungenarterienembolie ist eine der häufigsten Differenzialdiagnosen bei Dyspnoe in der täglichen medizinischen Versorgung. Da die Prävalenz jedoch gering, das Spektrum der Symptome breit, die spezifischen Tests aufwändig sowie teuer und die Konsequenzen potenziell schwerwiegend sind, ist die essenzielle Grundlage der rationellen Diagnostik und Therapie eine besonders aufmerksame Anamnese und Untersuchung des Patienten.

Literatur

  1. 1.
    Coon WW, Willis PW. Deep venous thrombosis and pulmonary embolism: prediction, prevention and treatment. Am J Cardiol. 1959;4:611–21PubMedGoogle Scholar
  2. 2.
    Soloff LA, Rodman T. Acute pulmonary embolism. II. Clinical. Am Heart J. 1967;74(6):829–47PubMedGoogle Scholar
  3. 3.
    Ryu JH, Pellikka PA, Froehling DA et al. Saddle pulmonary embolism diagnosed by CT angiography: frequency, clinical features and outcome. Respir Med. 2007;101(7):1537–42PubMedGoogle Scholar
  4. 4.
    Sardi A, Gluskin J, Guttentag A et al. Saddle pulmonary embolism: is it as bad as it looks? A community hospital experience. Crit Care Med. 2011;39(11):2413–8PubMedGoogle Scholar
  5. 5.
    Wiener RS, Schwartz LM, Woloshin S. Time trends in pulmonary embolism in the United States: evidence of overdiagnosis. Arch Intern Med. 2011;171(9):831–7PubMedPubMedCentralGoogle Scholar
  6. 6.
    Kröger K, Küpper-Nybelen J, Moerchel C et al. Prevalence and economic burden of pulmonary embolism in Germany. Vasc Med. 2012;17(5):303–9PubMedGoogle Scholar
  7. 7.
    Huang W, Goldberg RJ, Anderson FA et al. Secular trends in occurrence of acute venous thromboembolism: the Worcester VTE study (1985-2009). Am J Med. 2014;127(9):829–39.e5PubMedPubMedCentralGoogle Scholar
  8. 8.
    Goldacre MJ, Roberts S, Yeates D, Griffith M. Hospital admission and mortality rates for venous thromboembolism in Oxford region, UK, 1975-98. Lancet. 2000;355(9219):1968–9PubMedGoogle Scholar
  9. 9.
    Martinez C, Cohen AT, Bamber L, Rietbrock S. Epidemiology of first and recurrent venous thromboembolism: a population-based cohort study in patients without active cancer. Thromb Haemost. 2014;112(2):255–63PubMedGoogle Scholar
  10. 10.
    Alotaibi GS, Wu C, Senthilselvan A, McMurtry MS. Secular Trends in Incidence and Mortality of Acute Venous Thromboembolism: The AB-VTE Population-Based Study. Am J Med. 2016;129(8):879.e19–25Google Scholar
  11. 11.
    Konstantinides SV. Trends in incidence versus case fatality rates of pulmonary embolism: Good news or bad news? Thromb Haemost. 2016;115(2):233–5PubMedGoogle Scholar
  12. 12.
    Horlander KT, Mannino DM, Leeper KV. Pulmonary embolism mortality in the United States, 1979-1998: an analysis using multiple-cause mortality data. Arch Intern Med. 2003;163(14):1711–7PubMedGoogle Scholar
  13. 13.
    Silverstein MD, Heit JA, Mohr DN et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med. 1998;158(6):585–93PubMedGoogle Scholar
  14. 14.
    Naess IA, Christiansen SC, Romundstad P et al. Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost. 2007;5(4):692–9PubMedGoogle Scholar
  15. 15.
    Tagalakis V, Patenaude V, Kahn SR, Suissa S. Incidence of and mortality from venous thromboembolism in a real-world population: the Q-VTE Study Cohort. Am J Med. 2013;126(9):832.e13–21Google Scholar
  16. 16.
    Lassila R, Jula A, Pitkäniemi J, Haukka J. The association of statin use with reduced incidence of venous thromboembolism: a population-based cohort study. BMJ Open. 2014;4(11):e005862PubMedPubMedCentralGoogle Scholar
  17. 17.
    Office of the Surgeon General (US); National Heart, Lung, and Blood Institute (US). The Surgeon General’s Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism. Rockville (MD): Office of the Surgeon General (US); 2008Google Scholar
  18. 18.
  19. 19.
    Cohen AT, Agnelli G, Anderson FA et al. Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost. 2007;98(4):756–64PubMedGoogle Scholar
  20. 20.
    Smith SB, Geske JB, Kathuria P et al. Analysis of National Trends in Admissions for Pulmonary Embolism. Chest. 2016;150(1):35–45PubMedPubMedCentralGoogle Scholar
  21. 21.
    Søgaard KK, Schmidt M, Pedersen L et al. 30-year mortality after venous thromboembolism: a population-based cohort study. Circulation. 2014;130(10):829–36PubMedGoogle Scholar
  22. 22.
    Stein PD, Beemath A, Matta F et al. Clinical characteristics of patients with acute pulmonary embolism: data from PIOPED II. Am J Med. 2007;120(10):871–9PubMedPubMedCentralGoogle Scholar
  23. 23.
    PIOPED Investigators. Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). JAMA. 1990;263(20):2753–9Google Scholar
  24. 24.
    Darze ES, Latado AL, Guimarães AG et al. Incidence and clinical predictors of pulmonary embolism in severe heart failure patients admitted to a coronary care unit. Chest. 2005;128(4):2576–80PubMedGoogle Scholar
  25. 25.
    Heit JA, O’Fallon WM, Petterson TM et al. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Intern Med. 2002;162(11):1245–8PubMedGoogle Scholar
  26. 26.
    Pulido T, Aranda A, Zevallos MA, et al. Pulmonary embolism as a cause of death in patients with heart disease: an autopsy study. Chest. 2006;129(5):1282–7PubMedGoogle Scholar
  27. 27.
    Zöller B, Li X, Sundquist J, Sundquist K. Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden. Lancet. 2012;379(9812):244–9PubMedGoogle Scholar
  28. 28.
    Goldhaber SZ, Grodstein F, Stampfer MJ et al. A prospective study of risk factors for pulmonary embolism in women. JAMA. 1997;277(8):642–5PubMedGoogle Scholar
  29. 29.
    Gohil R, Peck G, Sharma P. The genetics of venous thromboembolism. A meta-analysis involving approximately 120,000 cases and 180,000 controls. Thromb Haemost. 2009;102(2):360–70PubMedGoogle Scholar
  30. 30.
    Germain M, Chasman DI, deHaan H et al. Meta-analysis of 65,734 individuals identifies TSPAN15 and SLC44A2 as two susceptibility loci for venous thromboembolism. Am J Hum Genet. 2015;96(4):532–42PubMedPubMedCentralGoogle Scholar
  31. 31.
    Girard P, Decousus M, Laporte S et al. Diagnosis of pulmonary embolism in patients with proximal deep vein thrombosis: specificity of symptoms and perfusion defects at baseline and during anticoagulant therapy. Am J Respir Crit Care Med. 2001;164(6):1033–7PubMedGoogle Scholar
  32. 32.
    Kistner RL, Ball JJ, Nordyke RA, Freeman GC. Incidence of pulmonary embolism in the course of thrombophlebitis of the lower extremities. Am J Surg. 1972;124(2):169–76PubMedGoogle Scholar
  33. 33.
    Moser KM, LeMoine JR. Is embolic risk conditioned by location of deep venous thrombosis? Ann Intern Med. 1981;94(4 pt 1):439–44PubMedGoogle Scholar
  34. 34.
    Weinmann EE, Salzman EW. Deep-vein thrombosis. N Engl J Med. 1994;331(24):1630–41PubMedGoogle Scholar
  35. 35.
    van Langevelde K, Srámek A, Vincken PW et al. Finding the origin of pulmonary emboli with a total-body magnetic resonance direct thrombus imaging technique. Haematologica. 2013;98(2):309–15PubMedPubMedCentralGoogle Scholar
  36. 36.
    Kearon C. Natural history of venous thromboembolism. Circulation. 2003;107(23 Suppl 1):I22–30PubMedGoogle Scholar
  37. 37.
    Masuda EM, Kistner RL. The case for managing calf vein thrombi with duplex surveillance and selective anticoagulation. Dis Mon. 2010;56(10):601–13PubMedGoogle Scholar
  38. 38.
    Righini M, Paris S, Le Gal G et al. Clinical relevance of distal deep vein thrombosis. Review of literature data. Thromb Haemost. 2006;95(1):56–64PubMedGoogle Scholar
  39. 39.
    Schwarz T, Schmidt B, Beyer J, Schellong SM. Therapy of isolated calf muscle vein thrombosis with low-molecular-weight heparin. Blood Coagul Fibrinolysis. 2001;12(7):597–9PubMedGoogle Scholar
  40. 40.
    Macdonald PS, Kahn SR, Miller N, Obrand D. Short-term natural history of isolated gastrocnemius and soleal vein thrombosis. J Vasc Surg. 2003;37(3):523–7PubMedGoogle Scholar
  41. 41.
    Gillet JL, Perrin MR, Allaert FA. Short-term and mid-term outcome of isolated symptomatic muscular calf vein thrombosis. J Vasc Surg. 2007;46(3):513–9PubMedGoogle Scholar
  42. 42.
    Lautz TB, Abbas F, Walsh SJ et al. Isolated gastrocnemius and soleal vein thrombosis: should these patients receive therapeutic anticoagulation? Ann Surg. 2010;251(4):735–42PubMedGoogle Scholar
  43. 43.
    Schwarz T, Buschmann L, Beyer J et al. Therapy of isolated calf muscle vein thrombosis: a randomized, controlled study. J Vasc Surg. 2010;52(5):1246–50PubMedGoogle Scholar
  44. 44.
    Sales CM, Haq F, Bustami R, Sun F. Management of isolated soleal and gastrocnemius vein thrombosis. J Vasc Surg. 2010;52(5):1251–4PubMedGoogle Scholar
  45. 45.
    Palareti G, Cosmi B, Lessiani G et al. Evolution of untreated calf deep-vein thrombosis in high risk symptomatic outpatients: the blind, prospective CALTHRO study. Thromb Haemost. 2010;104(5):1063–70PubMedGoogle Scholar
  46. 46.
    Moser KM. Venous thromboembolism. Am Rev Respir Dis. 1990;141(1):235–49PubMedGoogle Scholar
  47. 47.
    Stein PD, Terrin ML, Hales CA et al. Clinical, laboratory, roentgenographic, and electrocardiographic findings in patients with acute pulmonary embolism and no pre-existing cardiac or pulmonary disease. Chest. 1991;100(3):598–603PubMedGoogle Scholar
  48. 48.
    Nakos G, Kitsiouli EI, Lekka ME. Bronchoalveolar lavage alterations in pulmonary embolism. Am J Respir Crit Care Med. 1998;158(5 Pt 1):1504–10PubMedGoogle Scholar
  49. 49.
    Benotti JR, Dalen JE. The natural history of pulmonary embolism. Clin Chest Med. 1984;5(3):403–10PubMedGoogle Scholar
  50. 50.
    Flinterman LE, van Hylckama Vlieg A, Cannegieter SC, Rosendaal FR. Long-term survival in a large cohort of patients with venous thrombosis: incidence and predictors. PLoS Med. 2012;9(1):e1001155PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2019

Authors and Affiliations

  1. 1.Medizinische Klinik II — Kardiologie, Angiologie, Internistische IntensivmedizinSt. Marien-Krankenhaus Siegen GmbHSiegenDeutschland

Personalised recommendations